NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 262 filers reported holding NEKTAR THERAPEUTICS in Q2 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $11 | -78.8% | 16,233 | 0.0% | 0.00% | – |
Q4 2022 | $52 | -99.9% | 16,233 | 0.0% | 0.00% | – |
Q3 2022 | $52,000 | -16.1% | 16,233 | 0.0% | 0.00% | – |
Q2 2022 | $62,000 | +24.0% | 16,233 | +75.4% | 0.00% | – |
Q1 2022 | $50,000 | -56.9% | 9,254 | +8.0% | 0.00% | – |
Q4 2021 | $116,000 | -11.5% | 8,572 | +17.3% | 0.00% | – |
Q3 2021 | $131,000 | -47.6% | 7,308 | -50.0% | 0.00% | – |
Q2 2021 | $250,000 | -14.4% | 14,616 | 0.0% | 0.00% | -100.0% |
Q1 2021 | $292,000 | -78.6% | 14,616 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $1,366,000 | +642.4% | 14,616 | +31.6% | 0.00% | 0.0% |
Q3 2020 | $184,000 | -94.8% | 11,110 | -92.8% | 0.00% | -91.7% |
Q2 2020 | $3,558,000 | -44.4% | 153,612 | -57.2% | 0.01% | -77.8% |
Q1 2020 | $6,400,000 | -36.2% | 358,535 | -22.8% | 0.05% | -14.3% |
Q4 2019 | $10,028,000 | +1268.1% | 464,605 | +1054.0% | 0.06% | +1160.0% |
Q3 2019 | $733,000 | +38.3% | 40,260 | +170.2% | 0.01% | +25.0% |
Q2 2019 | $530,000 | +6.0% | 14,898 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $500,000 | +27.6% | 14,898 | +24.9% | 0.00% | 0.0% |
Q4 2018 | $392,000 | -44.8% | 11,925 | +2.4% | 0.00% | -20.0% |
Q3 2018 | $710,000 | +24.8% | 11,645 | 0.0% | 0.01% | 0.0% |
Q2 2018 | $569,000 | -61.4% | 11,645 | -52.9% | 0.01% | -61.5% |
Q4 2017 | $1,476,000 | +81.1% | 24,716 | -47.9% | 0.01% | +30.0% |
Q3 2016 | $815,000 | +161.2% | 47,413 | +116.3% | 0.01% | +150.0% |
Q2 2016 | $312,000 | – | 21,917 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TIRSCHWELL & LOEWY INC | 588,908 | $7,138,000 | 1.23% |
Granahan Investment Management | 3,693,956 | $44,771,000 | 1.21% |
NEA Management Company, LLC | 1,825,600 | $22,126,000 | 1.09% |
FIC CAPITAL INC | 150,868 | $1,829,000 | 0.75% |
Rhenman & Partners Asset Management AB | 181,797 | $2,203,000 | 0.66% |
SOPHROSYNE CAPITAL LLC | 60,200 | $728,000 | 0.64% |
HARVEY CAPITAL MANAGEMENT INC | 130,400 | $1,580,000 | 0.63% |
Artal Group S.A. | 1,300,000 | $15,756,000 | 0.57% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 564,418 | $6,840,000 | 0.47% |
OppenheimerFunds, Inc. | 24,400,000 | $295,728,000 | 0.35% |